According to the National Institutes of Health (NIH), stem cells are 1-inch cells that can infinitely divide and produce specialized cells during culture. It can become a special cell. Specialized cells are often called differentiated cells. These differentiated cells repair damaged cells and can eventually be used to cure many human diseases and conditions. This may revolutionize the way society deals with health problems.
Discussions on financing for embryonic stem cell research are highly dependent on the ethical state of the study. There are two main arguments surrounding the ethics of embryonic stem cell research: research is ethically important due to the unique possibilities of embryonic stem cells to heal disease which is currently incurable disease. This research is immoral as it requires destruction of life in the form of an embryo or a fetus. After all, research on embryonic stem cells is considered moral as long as the stem cells are acquired in an ethical way, and the state of life that is possibly profitable and controversial is embodied in the embryo .
Discussions on the ethics of embryonic stem cell research have for many years separated scientists, politicians, and religious groups. However, promising development in other areas of stem cell research, avoiding the need to destroy the blastocyst, avoids these ethical barriers and gains more support for embryonic stem cell research Bring a helping solution. The use of blood, umbilical cord blood, skin and other tissue-derived stem cells called induced pluripotent stem cells (IPSC) has been demonstrated to be effective in the treatment of different diseases in animal models. Umbilical cord derived stem cells obtained from umbilical cord blood have also been isolated and have been used in various experimental procedures. Another option is to use single-parent stem cells.